Disclosure Of Entity's Operating Segments [Text Block]

Bayer AG - Filing #6464694

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of entity's operating segments [text block]
Der Bayer-Konzern besteht zum 31. Dezember 2024 aus den drei berichtspflichtigen Segmenten Crop Science, Pharmaceuticals und Consumer Health. Diese umfassen die folgenden Aktivitäten:
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
46,606,000 EUR
47,637,000 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method
132,000,000 EUR
162,000,000 EUR
Tax expense (income)
212,000,000 EUR
1,321,000 EUR
Profit (loss) before tax
2,334,000 EUR
1,621,000 EUR
Profit (loss) from continuing operations
2,546,000 EUR
2,942,000 EUR
Profit (loss)
6,000,000 EUR
2,546,000 EUR
2,552,000 EUR
2,552,000 EUR
2,942,000 EUR
1,000,000 EUR
2,941,000 EUR
2,941,000 EUR
Assets
110,850,000 EUR
116,259,000 EUR
Investments accounted for using equity method
820,000,000 EUR
850,000,000 EUR
Cash flows from (used in) operating activities
7,368,000 EUR
5,117,000 EUR
Cash flows from (used in) investing activities
164,000,000 EUR
3,517,000 EUR
Cash flows from (used in) financing activities
7,178,000 EUR
679,000,000 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.